The value of academic-industry relationships: Unhealthy Opposition

May 10, 2010 at 8:30 pm Leave a comment

This one is worth a read regardless of your position on this issue.

Boston Review, May/June 2010 by Thomas P. Stossel

“Corporate involvement in medical research and education: sin or salvation? The answer depends on how you approach the question.

You get one answer if you rely on what you think are self-evident beliefs, akin to religion, to be imposed on all by powerful authorities. You get a very different answer when you look to rigorous scholarly analysis dependent upon empirical facts and logic rooted in practical experience and the canons of history, economics, and the epistemology of science………..”

Read More

Thomas P. Stossel is American Cancer Society Professor of Medicine at Harvard Medical School, Senior Physician at Brigham and Women’s Hospital, and co-founder of Critical Biologics Corporation.

Advertisements

Entry filed under: CME, Pharma Funding.

PI (CME) Opportunity PI CME: Are There Opportunities in Healthcare Reform?

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Trackback this post  |  Subscribe to the comments via RSS Feed


Calendar

May 2010
M T W T F S S
« Apr   Jun »
 12
3456789
10111213141516
17181920212223
24252627282930
31  

Most Recent Posts


%d bloggers like this: